Mereo BioPharma Group plc
MREO
$1.74
$0.042.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.45% | 12.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.93% | -25.05% | |||
| Operating Income | 11.46% | 25.05% | |||
| Income Before Tax | -13.42% | -82.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.42% | -82.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.42% | -82.90% | |||
| EBIT | 11.46% | 25.05% | |||
| EBITDA | 11.78% | 25.28% | |||
| EPS Basic | -11.19% | -80.66% | |||
| Normalized Basic EPS | -11.31% | -80.63% | |||
| EPS Diluted | -11.19% | -80.66% | |||
| Normalized Diluted EPS | -11.31% | -80.63% | |||
| Average Basic Shares Outstanding | 1.93% | 1.19% | |||
| Average Diluted Shares Outstanding | 1.93% | 1.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||